Prostate Cancer Treatment Draws Fire
Posted on: Friday, 18 January 2008, 09:00 CST
U.S. medical tourists are headed to Latin American health clinics to receive a controversial prostate cancer treatment not approved in the United States.
High-intensity focused ultrasound, or HIFU therapy, uses isolated bursts of near-boiling temperatures to attack cancerous tissues in the prostate through a rectal probe, The New York Times reported Friday.
U.S. HIFU, a company touting the treatment at international clinics, said the treatment provides an alternative to more conventional treatment without the sexual or urinary side-effects of other treatments.
The director of the U.S. HIFU, Dr. George M. Suarez, told the Times the treatment's $25,000 price tag is justified and claimed the treatment is an alternative to surgery or radiation with fewer side effects.
U.S. HIFU is sponsoring FDA-approved clinical studies to win approval for the treatment in the United States. Canadian and EU officials have approved the treatment.
Dr. Peter Scardino with the Memorial Sloan-Kettering Cancer Center told the Times the treatment does provide an alternative method but added that for the treatment of the average ordinary prostate cancer, I think it's a second-class form of therapy.
Source: United Press International
Related Articles
- Lifestyle Interventions In The Prevention, Treatment Of Cancer
- Provenance Biopharmaceuticals Corp. Announces License Agreement with Merck Serono for the Development and Commercialization of Novel Immunocytokine for the Treatment of Cancer
- Sonablate(R) International HIFU Registry is the First Worldwide HIFU Clinical Registry for Prostate Cancer Treatments
- Noninvasive Imaging of Cell-Mediated Therapy for Treatment of Cancer
- St. Mary Medical Center Announces a $13+ Million Investment in Five New Significant Advances in Early Diagnosis and Treatment of Cancer
- The Cancer Cure Coalition Supports the Nomination of Dr. Andrew Von Eschenbach As Commissioner of the U.S. FDA and Calls for the Approval of Advexin, a New Gene Therapy Treatment for Cancer
- Cyberonics Announces 1,100th Patient Treated With VNS Therapy(Tm) for Treatment-Resistant Depression (TRD) Since FDA Approval
- Varian Introduces Advanced Real-Time Treatment Planning System to Expedite Prostate Cancer Brachytherapy Treatments
- Aethlon Medical Expands Device Pipeline to Include the Treatment of Cancer
- Major Breakthrough in the Treatment of Cancers and Infectious Diseases
 |
 |
User Comments (0)
RSS Feeds